Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612401 · ClinicalTrials.gov registry record · Early Phase 1
Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron
A Early Phase 1 study of Spinal Cord Injuries and Cognitive Change, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03612401 is a Early Phase 1 study of Spinal Cord Injuries and Cognitive Change that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 20 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03612401, a Early Phase 1 study of Spinal Cord Injuries and Cognitive Change, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
We propose to test the hypothesis that cognition will improve with substitution of mirabegron for the anticholinergic agent (AC) in elderly persons with spinal cord injury (SCI) who require neurogenic bladder (NGB) treatment.
Conditions Studied
Interventions
- DRUG Mirabegron
Study Locations (1)
Texas
- South Texas Veterans Health Care System, Audie L. Murphy Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2021-03-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612401
The ClinicalTrials.gov registry entry for NCT03612401 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (67% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Mirabegron is the first listed.
NCT03612401 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03612401 about?
NCT03612401 is a clinical study titled "Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron". We propose to test the hypothesis that cognition will improve with substitution of mirabegron for the anticholinergic agent (AC) in elderly persons with spinal cord injury (SCI) who require neurogenic bladder (NGB) treatment.
What is the current status of trial NCT03612401?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2018-12-05. Estimated completion is 2021-03-31.
What conditions does trial NCT03612401 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Cognitive Change, Neurogenic Bladder.
What interventions are being tested in trial NCT03612401?
The interventions under investigation include: Mirabegron (DRUG).
Who is sponsoring clinical trial NCT03612401?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03612401 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation to Reduce Muscle Stiffness Following Spinal Cord Injury
RECRUITING · Early Phase 1
-
Transformation of Paralysis to Stepping
ACTIVE NOT RECRUITING · Early Phase 1
-
Transdermal Administration by a Novel Wireless Iontophoresis Device
COMPLETED · Early Phase 1
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.